February 20, 2026
Projections indicate that, the global monoclonal antibodie market will increase from USD 254.89 billion in 2024 to USD 823.31 billion by 2034, experiencing a CAGR of 12.44% over the next 10 years. The monoclonal antibodies market is expanding due t...
July 13, 2026
Based on market forecasts, the monoclonal antibodies in veterinary health sector will expand from USD 1.70 billion in 2026 to USD 7.05 billion by 2035, experiencing a CAGR of 17.13%. In 2024, North America led the veterinary monoclonal antibodies mar...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
October 15, 2026
According to Payal Rabde, who specializes in oncology biosimilars, inflammatory disease management, targeted biologic therapies, and biosimilar versions of monoclonal antibody therapies, with 4+ years of experience in market research and industry ana...
February 05, 2026
According to our forecasts, the humanized monoclonal antibody market was valued at USD 170.04 billion in 2025 and is projected to reach USD 190.34 billion in 2026, expanding to USD 525.3 billion by 2035 at a CAGR of 11.94% from 2026 to 2035....
February 09, 2026
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segment...
April 21, 2026
According to market projections, the monoclonal antibody discovery platform sector is expected to grow from USD 3.66 billion in 2025 to USD 11.93 billion by 2035, reflecting a CAGR of 12.55% that covers manufacturers, suppliers, value chain insights,...
July 24, 2026
Market insights predict, the antibodies drug industry is expected to grow from USD 272.3 billion in 2026 to USD 759.36 billion by 2035, driven by a CAGR of 10.8%. The increase in the production of monoclonal antibodies is leading to higher demand for...
April 21, 2026
According to forecasts, the global polyclonal antibodies market will grow from USD 1.68 billion in 2024 to USD 2.74 billion by 2034, with an expected CAGR of 5.04%. Growing cases of diseases is driving the usage of polyclonal antibodies....
September 15, 2026
According to Payal Rabde, who specializes in healthcare and life sciences market research and industry analysis with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the rese...
October 15, 2026
The global biosimilar antibodies market size is expected to reach from $44.31B in 2026 to $153.46B by 2035. The market is predicted to grow at a 14.8% CAGR during the forecast period. Factors like expiration of patents, interest in cost-efficient hea...
July 21, 2026
According to Payal Rabde, who specializes in the management of Parkinson’s disease, essential tremor, dystonia, and epilepsy, advanced implantable pulse generators, and AI-enabled programming and remote device monitoring, with 4+ years of exper...
April 21, 2026
According to market projections, the global epigenetic antibodies market, valued at USD 2.29 billion in 2024, is anticipated to reach USD 12.01 billion by 2034, growing at a CAGR of 18.04% over the next decade.The epigenetic antibodies market is grow...
May 26, 2026
Multispecific Antibodies (By Therapy Type: Bispecific Antibodies, Trispecific Antibodies, Other Multispecific Antibodies; By Application: Oncology, Autoimmune Diseases, Infectious Diseases, Other Therapeutic Areas; By Drug Class: Monoclonal Antibodie...
+1 9197 992 333
+91 93077 85324
